help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raaphorst, F. M.
Right arrow Articles by Meijer, C. J.L.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raaphorst, F. M.
Right arrow Articles by Meijer, C. J.L.M.
(American Journal of Pathology. 2004;164:533-542.)
© 2004 American Society for Investigative Pathology

Site-Specific Expression of Polycomb-Group Genes Encoding the HPC-HPH/PRC1 Complex in Clinically Defined Primary Nodal and Cutaneous Large B-Cell Lymphomas

Frank M. Raaphorst*, Maarten Vermeer{dagger}, Elly Fieret*, Tjasso Blokzijl*, Danny Dukers*, Richard G.A.B. Sewalt{ddagger}, Arie P. Otte{ddagger}, Rein Willemze{dagger} and Chris J.L.M. Meijer*

From the Department of Pathology,* Vrije Universiteit Medical Center, Amsterdam; the Swammerdam Institute for Life Sciences,{ddagger} University of Amsterdam, Amsterdam; and the Department of Dermatology,{dagger} Leiden University Medical Center, Leiden, The Netherlands

Polycomb-group (PcG) genes preserve cell identity by gene silencing, and contribute to regulation of lymphopoiesis and malignant transformation. We show that primary nodal large B-cell lymphomas (LBCLs), and secondary cutaneous deposits from such lymphomas, abnormally express the BMI-1, RING1, and HPH1 PcG genes in cycling neoplastic cells. By contrast, tumor cells in primary cutaneous LBCLs lacked BMI-1 expression, whereas RING1 was variably detected. Lack of BMI-1 expression was characteristic for primary cutaneous LBCLs, because other primary extranodal LBCLs originating from brain, testes, and stomach were BMI-1-positive. Expression of HPH1 was rarely detected in primary cutaneous LBCLs of the head or trunk and abundant in primary cutaneous LBCLs of the legs, which fits well with its earlier recognition as a distinct clinical pathological entity with different clinical behavior. We conclude that clinically defined subclasses of primary LBCLs display site-specific abnormal expression patterns of PcG genes of the HPC-HPH/PRC1 PcG complex. Some of these patterns (such as the expression profile of BMI-1) may be diagnostically relevant. We propose that distinct expression profiles of PcG genes results in abnormal formation of HPC-HPH/PRC1 PcG complexes, and that this contributes to lymphomagenesis and different clinical behavior of clinically defined LBCLs.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. Silva, J. M. Garcia, C. Pena, V. Garcia, G. Dominguez, D. Suarez, F. I. Camacho, R. Espinosa, M. Provencio, P. Espana, et al.
Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas
Clin. Cancer Res., December 1, 2006; 12(23): 6929 - 6936.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
F. M. Raaphorst
Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R93 - R100.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.